Genpact Limited (NYSE:G) Shares Sold by Johnson Investment Counsel Inc.

Johnson Investment Counsel Inc. decreased its position in Genpact Limited (NYSE:G - Free Report) by 32.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 53,290 shares of the business services provider's stock after selling 26,170 shares during the quarter. Johnson Investment Counsel Inc.'s holdings in Genpact were worth $2,685,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. Coppell Advisory Solutions LLC grew its stake in Genpact by 529.5% during the 4th quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock valued at $25,000 after purchasing an additional 503 shares in the last quarter. Atlas Capital Advisors Inc. grew its position in shares of Genpact by 55.8% during the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after buying an additional 216 shares in the last quarter. GeoWealth Management LLC grew its position in shares of Genpact by 199.0% during the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock worth $38,000 after buying an additional 583 shares in the last quarter. Smartleaf Asset Management LLC grew its position in shares of Genpact by 416.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock worth $41,000 after buying an additional 783 shares in the last quarter. Finally, J.Safra Asset Management Corp grew its holdings in Genpact by 38.8% during the 4th quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider's stock worth $69,000 after acquiring an additional 453 shares in the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Robert W. Baird decreased their price objective on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Wall Street Zen upgraded Genpact from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 6th. Finally, Needham & Company LLC decreased their target price on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research report on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $50.71.

Insider Buying and Selling at Genpact

In other Genpact news, Director Nicholas C. Gangestad purchased 2,000 shares of Genpact stock in a transaction on Tuesday, May 13th. The stock was bought at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the transaction, the director now owns 2,000 shares of the company's stock, valued at $87,940. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 3.07% of the stock is currently owned by company insiders.

Genpact Stock Down 3.5%

NYSE:G opened at $40.63 on Friday. The firm has a market capitalization of $7.10 billion, a PE ratio of 13.87, a price-to-earnings-growth ratio of 1.59 and a beta of 0.94. The stock has a 50 day moving average of $45.09 and a 200-day moving average of $46.99. Genpact Limited has a 52 week low of $30.38 and a 52 week high of $56.76. The company has a current ratio of 2.45, a quick ratio of 2.45 and a debt-to-equity ratio of 0.48.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.80 by $0.04. Genpact had a return on equity of 22.35% and a net margin of 10.88%. The business had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.21 billion. During the same quarter in the previous year, the firm posted $0.73 EPS. The business's revenue for the quarter was up 7.4% compared to the same quarter last year. Analysts predict that Genpact Limited will post 3.21 EPS for the current year.

Genpact Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Wednesday, June 18th will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.67%. The ex-dividend date is Wednesday, June 18th. Genpact's payout ratio is 23.21%.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.